ClearBridge Investments’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-539,905
Closed -$21.7M 760
2023
Q3
$21.7M Sell
539,905
-1,478
-0.3% -$69.2K 0.02% 413
2023
Q2
$28.5M Buy
541,383
+1,165
+0.2% +$70.9K 0.03% 393
2023
Q1
$34.5M Buy
540,218
+14,930
+3% +$974K 0.03% 373
2022
Q4
$25.5M Buy
525,288
+4,451
+0.9% +$279K 0.03% 404
2022
Q3
$36.7M Buy
520,837
+2,300
+0.4% +$197K 0.04% 355
2022
Q2
$36.8M Buy
518,537
+113,848
+28% +$7.34M 0.03% 371
2022
Q1
$32.3M Buy
+404,689
New +$30.1M 0.02% 410

Other funds holding STAA

ClearBridge Investments's STAA Position: Q4 2023 in Review

ClearBridge Investments sold out of STAAR Surgical (STAA) in Q4 2023, closing a stake of 539,905 shares — an estimated $21.7M sold.

ClearBridge Investments first reported a position in STAA in Q1 2022 and held it in 7 quarters. The position peaked at $36.8M in Q2 2022. 207 funds tracked by Wall St. Rank hold STAA as of Q4 2023.

  • ClearBridge Investments reported no remaining STAAR Surgical position as of Q4 2023 after selling out during the quarter.
  • ClearBridge Investments sold 539,905 STAAR Surgical shares in Q4 2023, an estimated $21.7M.
  • ClearBridge Investments first reported a position in STAAR Surgical in Q1 2022 and held it in 7 quarters.
  • ClearBridge Investments's STAAR Surgical position peaked at $36.8M in Q2 2022.
  • 207 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2023.

Based on ClearBridge Investments's 13F filing for Q4 2023, filed 9 Feb 2024.